Continued Certification, Registration Confirm Company’s Adherence to U.S. FDA .
Good Manufacturing Practices (GMP) in Production of Pharmaceutical Products and Dietary Supplements
TAMARAC, Fla. (May 11, 2021) — New Vision Pharmaceuticals, a contract pharmaceutical development and manufacturing company specializing in blow-fill-seal packaging, is pleased to announce that it has once again achieved Good Manufacturing Practices (GMP) certification from Underwriting Laboratories (UL) for over-the-counter (OTC) drug production. In addition, the company is proud to announce its renewed registration as a GMP facility from NSF International.
“Both the UL certification and NSF International registration reflect our ongoing commitment to quality through adherence to current GMPs as defined by the U.S. Food and Drug Administration,” said Alan Petro, CEO of New Vision Pharmaceuticals. “We are proud of our entire team’s efforts in achieving these designations, and especially the dedication and expertise of our quality control staff.”
Both the UL certification and NSF International registration reflect our ongoing commitment to quality through adherence to current GMPs as defined by the U.S. Food and Drug Administration
— Alan Petro, CEO
The UL certification shows the New Vision Pharmaceuticals facility passed an audit and conforms with GMPs per the U.S. FDA’s 21 CFR Parts 201 and 211 for pharmaceutical products. For NSF International registration, the facility underwent rigorous audits that verify use of proper methods, equipment, facilities and controls for producing dietary supplement products per U.S. Food and Drug Administration (FDA) 21 CFR Part 111.
“We pride ourselves in meeting and exceeding GMPs as required by the FDA, UL and NSF, as quality remains our central focus,” said Sarah Serrano, director of Quality for New Vision Pharmaceuticals. “Our proven processes, procedures and documentation assure clients that products from our facility adhere to the necessary regulatory requirements.”
The UL certification and NSF International registration were received March and April of 2021, respectively. For more information on solutions from New Vision Pharmaceutical, visit here.
About New Vision Pharmaceuticals
New Vision Pharmaceuticals is a full-service, FDA-registered contract development and manufacturing company that provides innovative solutions through blow-fill-seal (BFS), fill-seal (FS) and traditional packaging for liquid and semi-solid products in a breadth of industries. These industries include pharmaceutical, diagnostic reagent, dietary supplement and a multitude of other applications. With headquarters and state-of-the-art manufacturing facilities located in Tamarac, Fla., near the international logistics hub of Miami, New Vision Pharmaceuticals provides an economical avenue to deliver products at scale, quickly, safely and effectively. These products are fulfilled in the exact formulation you need, from single dose to traditional packaging. New Vision Pharmaceuticals prides itself on working directly with clients as a true partner to deliver tailor-made products for their individual applications, providing peace of mind through excellence in quality, reliability and service. Visit newvisionpharmaceuticals.com for more information on solutions for your product development and packaging needs, and follow us on Twitter at @NewVisionPharm1, LinkedIn and Facebook.
Media Contact:
Jan Sisko
Carabiner Communications
O: 678.461.7438
M: 678.591.2022
jsisko@carabinercomms.com
